ONCAlert | Upfront Therapy for mRCC
Videos
Challenges to Overcome in Treating Multiple Myeloma
2:00 PM, Wed December 4, 2019
Enhancing Benefit With Durvalumab in NSCLC After the PACIFIC Trial
4:00 PM, Tue December 3, 2019
.jpg "Brentuximab Vedotin Adds Benefit to A+AVD Therapy in cHL")
Brentuximab Vedotin Adds Benefit to A+AVD Therapy in cHL
3:00 PM, Tue December 3, 2019
Immunotherapy Versus Targeted Therapy for Advanced Melanoma
9:15 PM, Mon December 2, 2019
Continuing the Overall Survival Analysis in the MONARCH-2 Trial
7:18 PM, Mon December 2, 2019
Treatments Improve PFS in Thyroid Cancer
3:19 PM, Wed November 27, 2019
Telemedicine Improves Accessibility of CAR T-Cell Therapy
8:41 PM, Tue November 26, 2019
Erlotinib Plus Ramucirumab Show Promising Activity in EGFR+ Lung Cancer
8:01 PM, Mon November 25, 2019
